Literature DB >> 18757372

Tetrasulfated disaccharide unit in heparan sulfate: enzymatic formation and tissue distribution.

Hideo Mochizuki1, Keiichi Yoshida, Yuniko Shibata, Koji Kimata.   

Abstract

We previously reported that the heparan sulfate 3-O-sulfotransferase (3OST)-5 produces a novel component of heparan sulfate, i.e. the tetrasulfated disaccharide (Di-tetraS) unit ( Mochizuki, H., Yoshida, K., Gotoh, M., Sugioka, S., Kikuchi, N., Kwon, Y.-D., Tawada, A., Maeyama, K., Inaba, N., Hiruma, T., Kimata, K., and Narimatsu, H. (2003) J. Biol. Chem. 278, 26780-26787 ). In the present study, we investigated the potential of other 3OST isoforms to produce Di-tetraS with heparan sulfate and heparin as acceptor substrates. 3OST-2, 3OST-3, and 3OST-4 produce Di-tetraS units as a major product from both substrates. 3OST-5 showed the same specificity for heparin, but the production from heparan sulfate was very low. Di-tetraS production by 3OST-1 was negligible. We then investigated the presence of Di-tetraS units in heparan sulfates from various rat tissues. Di-tetraS was detected in all of the tissues analyzed. Liver and spleen contain relatively high levels of Di-tetraS, 1.6 and 0.95%, respectively. However, the content of this unit in heart, large intestine, ileum, and lung is low, less than 0.2%. We further determined the expression levels of 3OST transcripts by quantitative real time PCR. The 3OST-3 transcripts are highly expressed in spleen and liver. The 3OST-2 and -4 are specifically expressed in brain. These results indicate that the Di-tetraS unit is widely distributed throughout the body as a rare and unique component of heparan sulfate and is synthesized by tissue-specific 3OST isoforms specific for Di-tetraS production.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18757372      PMCID: PMC2662186          DOI: 10.1074/jbc.M801586200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  53 in total

1.  3'-minor groove binder-DNA probes increase sequence specificity at PCR extension temperatures.

Authors:  I V Kutyavin; I A Afonina; A Mills; V V Gorn; E A Lukhtanov; E S Belousov; M J Singer; D K Walburger; S G Lokhov; A A Gall; R Dempcy; M W Reed; R B Meyer; J Hedgpeth
Journal:  Nucleic Acids Res       Date:  2000-01-15       Impact factor: 16.971

2.  The putative tumor suppressors EXT1 and EXT2 form a stable complex that accumulates in the Golgi apparatus and catalyzes the synthesis of heparan sulfate.

Authors:  C McCormick; G Duncan; K T Goutsos; F Tufaro
Journal:  Proc Natl Acad Sci U S A       Date:  2000-01-18       Impact factor: 11.205

3.  Structural modification of fibroblast growth factor-binding heparan sulfate at a determinative stage of neural development.

Authors:  Y G Brickman; M D Ford; J T Gallagher; V Nurcombe; P F Bartlett; J E Turnbull
Journal:  J Biol Chem       Date:  1998-02-20       Impact factor: 5.157

4.  Structural analysis of glycosaminoglycans in Drosophila and Caenorhabditis elegans and demonstration that tout-velu, a Drosophila gene related to EXT tumor suppressors, affects heparan sulfate in vivo.

Authors:  H Toyoda; A Kinoshita-Toyoda; S B Selleck
Journal:  J Biol Chem       Date:  2000-01-28       Impact factor: 5.157

5.  Heparan sulfate D-glucosaminyl 3-O-sulfotransferase-3A sulfates N-unsubstituted glucosamine residues.

Authors:  J Liu; Z Shriver; P Blaiklock; K Yoshida; R Sasisekharan; R D Rosenberg
Journal:  J Biol Chem       Date:  1999-12-31       Impact factor: 5.157

6.  The principal neuronal gD-type 3-O-sulfotransferases and their products in central and peripheral nervous system tissues.

Authors:  Roger Lawrence; Tomio Yabe; Sassan Hajmohammadi; John Rhodes; Melissa McNeely; Jian Liu; Edward D Lamperti; Paul A Toselli; Miroslaw Lech; Patricia G Spear; Robert D Rosenberg; Nicholas W Shworak
Journal:  Matrix Biol       Date:  2007-03-30       Impact factor: 11.583

7.  Heparan sulfate proteoglycans provide a signal to Plasmodium sporozoites to stop migrating and productively invade host cells.

Authors:  Alida Coppi; Rita Tewari; Joseph R Bishop; Brandy L Bennett; Roger Lawrence; Jeffrey D Esko; Oliver Billker; Photini Sinnis
Journal:  Cell Host Microbe       Date:  2007-11-15       Impact factor: 21.023

Review 8.  Heparan sulphate proteoglycans fine-tune mammalian physiology.

Authors:  Joseph R Bishop; Manuela Schuksz; Jeffrey D Esko
Journal:  Nature       Date:  2007-04-26       Impact factor: 49.962

9.  Hepatitis B virus infection initiates with a large surface protein-dependent binding to heparan sulfate proteoglycans.

Authors:  Andreas Schulze; Philippe Gripon; Stephan Urban
Journal:  Hepatology       Date:  2007-12       Impact factor: 17.425

10.  Isolation and characterization of heparan sulfate from various murine tissues.

Authors:  Mohamad Warda; Toshihiko Toida; Fuming Zhang; Peilong Sun; Eva Munoz; Jin Xie; Robert J Linhardt
Journal:  Glycoconj J       Date:  2006-11       Impact factor: 2.916

View more
  21 in total

1.  Genome-wide siRNA screen reveals a new cellular partner of NK cell receptor KIR2DL4: heparan sulfate directly modulates KIR2DL4-mediated responses.

Authors:  Kerry S Campbell; Angel Porgador; Michael Brusilovsky; Moti Cordoba; Benyamin Rosental; Oren Hershkovitz; Mark D Andrake; Anna Pecherskaya; Margret B Einarson; Yan Zhou; Alex Braiman
Journal:  J Immunol       Date:  2013-10-14       Impact factor: 5.422

2.  HS3ST2 expression is critical for the abnormal phosphorylation of tau in Alzheimer's disease-related tau pathology.

Authors:  Julia Elisa Sepulveda-Diaz; Seyedeh Maryam Alavi Naini; Minh Bao Huynh; Mohand Ouidir Ouidja; Constantin Yanicostas; Sandrine Chantepie; Joao Villares; Foudil Lamari; Estelle Jospin; Toin H van Kuppevelt; Ayikoe Guy Mensah-Nyagan; Rita Raisman-Vozari; Nadia Soussi-Yanicostas; Dulce Papy-Garcia
Journal:  Brain       Date:  2015-04-04       Impact factor: 13.501

3.  3-O-Sulfation of Heparan Sulfate Enhances Tau Interaction and Cellular Uptake.

Authors:  Jing Zhao; Yanan Zhu; Xuehong Song; Yuanyuan Xiao; Guowei Su; Xinyue Liu; Zhangjie Wang; Yongmei Xu; Jian Liu; David Eliezer; Trudy F Ramlall; Guy Lippens; James Gibson; Fuming Zhang; Robert J Linhardt; Lianchun Wang; Chunyu Wang
Journal:  Angew Chem Int Ed Engl       Date:  2019-12-10       Impact factor: 15.336

4.  Sulfatase 1 is an inhibitor of ductal morphogenesis with sexually dimorphic expression in the urogenital sinus.

Authors:  Rita A Buresh; Sheri L Kuslak; Melissa A Rusch; Chad M Vezina; Scott B Selleck; Paul C Marker
Journal:  Endocrinology       Date:  2010-04-21       Impact factor: 4.736

5.  Cryo-EM structure of eastern equine encephalitis virus in complex with heparan sulfate analogues.

Authors:  Chun-Liang Chen; S Saif Hasan; Thomas Klose; Yingyuan Sun; Geeta Buda; Chengqun Sun; William B Klimstra; Michael G Rossmann
Journal:  Proc Natl Acad Sci U S A       Date:  2020-04-03       Impact factor: 11.205

Review 6.  Understanding the substrate specificity of the heparan sulfate sulfotransferases by an integrated biosynthetic and crystallographic approach.

Authors:  Jian Liu; Andrea F Moon; Juzheng Sheng; Lars C Pedersen
Journal:  Curr Opin Struct Biol       Date:  2012-07-26       Impact factor: 6.809

7.  Synthesis of heparan sulfate with cyclophilin B-binding properties is determined by cell type-specific expression of sulfotransferases.

Authors:  Audrey Deligny; Agnès Denys; Adeline Marcant; Aurélie Melchior; Joël Mazurier; Toin H van Kuppevelt; Fabrice Allain
Journal:  J Biol Chem       Date:  2009-11-23       Impact factor: 5.157

Review 8.  Heparan sulfate 3-O-sulfation: a rare modification in search of a function.

Authors:  Bryan E Thacker; Ding Xu; Roger Lawrence; Jeffrey D Esko
Journal:  Matrix Biol       Date:  2013-12-19       Impact factor: 11.583

9.  Changes in heparan sulfate sulfotransferases and cell-surface heparan sulfate during SKM-1 cells granulocytic differentiation and A549 cells epithelial-mesenchymal transition.

Authors:  Shancheng Zhao; Zhen Wang
Journal:  Glycoconj J       Date:  2019-12-20       Impact factor: 2.916

Review 10.  What Are the Potential Roles of Nuclear Perlecan and Other Heparan Sulphate Proteoglycans in the Normal and Malignant Phenotype.

Authors:  Anthony J Hayes; James Melrose
Journal:  Int J Mol Sci       Date:  2021-04-23       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.